|
FY2021
12 months to Dec 31, 2021
|
FY2020
1 months to Dec 31, 2020
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Interest earned on investments held in Trust Account | ||
| Formation costs paid by related parties | ||
| Change in fair value of warrant liabilities | ||
| Offering costs allocated to warrants | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Due to related party | ||
| Accrued offering costs and expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Net cash used in investing activities | ||
| Cash flows from Financing Activities: | ||
| Proceeds from issuance of promissory note to related party | ||
| Proceeds from sale of Units, net of underwriting discount | ||
| Proceeds from issuance of Private Placement Warrants | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash, beginning of the period | ||
| Cash, end of the period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock | ||
| Deferred offering costs included in accrued offering costs and expenses | ||
| Deferred underwriters' discount payable charged to additional paid-in capital |
Loading...
